The Challenges of CNS Drug Discovery. 4 March 2003, GlaxoSmithKline plc, Harlow, UK.
Norman
Peter
P
peter.norman2@btinternet.com
D015824:Blood-Air Barrier / Q000187:drug effects; D001921:Brain / Q000187:drug effects; D002491:Central Nervous System Agents / Q000493:pharmacokinetics / Q000494:pharmacology*; D003198:Computer Simulation; D003952:Diagnostic Imaging; D006801:Humans; D010600:Pharmacology; D018009:Receptors, Glycine / Q000037:antagonists & inhibitors; D018094:Receptors, Metabotropic Glutamate / Q000037:antagonists & inhibitors; D011985:Receptors, Serotonin / Q000187:drug effects; D012702:Serotonin Antagonists / Q000494:pharmacology
D002491:Central Nervous System Agents; D018009:Receptors, Glycine; D018094:Receptors, Metabotropic Glutamate; D011985:Receptors, Serotonin; D012702:Serotonin Antagonists; C104077:metabotropic glutamate receptor type 1; C097216:serotonin 6 receptor